Eugene P Kadar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Liquid Chromatography

Pluripotent Stem Cells

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Eugene P Kadar, Heather Eng, Amit S Kalgutkar, Christopher L Holliman, Gregory S Steeno
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor. Bioanalysis 16 (11) (2024)
Eugene P Kadar, Heather Eng, Amit S Kalgutkar, Christopher L Holliman, Gregory S Steeno
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor. Bioanalysis 16 (11) (2024)
Eugene P Kadar, Christopher L Holliman, Manoli Vourvahis, A David Rodrigues
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkers. Bioanalysis (2024)
Eugene P Kadar, Christopher L Holliman, Manoli Vourvahis, A David Rodrigues
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkers. Bioanalysis 16 (6) (2024)
Eugene P Kadar, Heather Eng, Amit S Kalgutkar, Christopher L Holliman, Gregory S Steeno
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor. Bioanalysis 16 (11) (2024)
Eugene P Kadar, Christopher L Holliman, Manoli Vourvahis, A David Rodrigues
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkers. Bioanalysis 16 (6) (2024)
Heather Eng, Alyssa L Dantonio, Eugene P Kadar, R Scott Obach, Li Di, Jian Lin, Nandini C Patel, Britton Boras, Gregory S Walker, Jonathan J Novak, Emi Kimito, Ravi Shankar Prasad Singh, Amit S Kalgutkar
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans. Drug metabolism and disposition: the biological fate of chemicals 50 (5) (2022)